Idiopathic Renal Infarction and Anticoagulation

Authors:

Abstract
Idiopathic renal infarction (iRI) is rare and the pathophysiology is not well understood.[1] There is no consensus treatment strategy for iRI, because previous studies have not reported long-term outcomes based on therapeutic intervention.[2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] We sought to determine if anticoagulation or nonanticoagulation was associated with a higher incidence of recurrent arterial thrombosis, de novo venous thrombosis, bleeding event, or development of long-term hypertension, proteinuria, or chronic kidney disease (CKD). The views expressed in this manuscript are those of the authors and do not reflect the official policy of the Department of the Army, Department of Defense, or the U.S. government.

This publication has 16 references indexed in Scilit: